Introduction {#sec1-1}
============

Alzheimer\'s disease (AD), one of the most common degenerative diseases of the central nervous system, is pathologically characterized by excessive deposition of senile plaques, neurofibrillary tangles and degeneration of synapses (Miranda et al., 2000). These pathological characteristics are mainly present in the hippocampus and cerebral cortex, which are associated with the learning and memory capacities of the brain. Currently, the mechanisms leading to AD remain controversial and the present hypotheses include pathogenic roles of amyloid-beta (Aβ) plaques (DeSantis et al., 2012; Liu et al., 2013b; Lu et al., 2013; Kim et al., 2014), tangles of hyperphosphorylated tau (Cohen et al., 2013), apoptosis caused by caspase (Pozueta et al., 2013), decrease of synapses (Kim et al., 2013; Pozueta et al., 2013), and losses of cholinergic neuron (Annunziata et al., 2013; Carvajal et al., 2013; Chen et al., 2013; Kim et al., 2013; Wang et al., 2014). However, the "Aβ hypothesis" is widely accepted as the dominant mechanism of pathogenesis in AD (Ziv et al., 2006; Liu et al., 2013a; Lu et al., 2013). That is, Aβ, the main component of amyloid plaques, aggregates in specific brain regions, produces a neurotoxic effect, and leads to synaptic damage and neuronal death, ultimately leading to the occurrence of AD.

Grassleaf sweetflag rhizome is a perennial herb belonging to the family Araceae. It is often used in traditional Chinese medicine in prescriptions for brain resuscitation and enlightenment because, according to traditional Chinese medicine theory, it has the effects of enlightening and tranquilization (Dong et al., 2014). Previous investigations have shown that the major ingredients of grassleaf sweetflag rhizome with these effects are β-asarone and eugenol (Xue et al., 2014). β-Asarone and eugenol, contained in the volatile oil (Dayer et al., 2005), are the main elements involved in protecting neurons. Both can cross the blood-brain barrier into the brain tissue and provide protective effects (Chen et al., 2014). To observe the mechanisms by which the volatile oil of grassleaf sweetflag rhizome protect against AD and to explore neuroprotective mechanisms of β-asarone and eugenol and a mixture of both, PC12 cell injury models were established using Aβ42 oligomers in this study.

Materials and Methods {#sec1-2}
=====================

Cell culture {#sec2-1}
------------

The PC12 cell line (Jinan University, Guangzhou, Guangdong Province, China) was cultured in 1640 culture medium (Hyclone, Logan, UT, USA) containing 10% fetal bovine serum (Hangzhou Sijiqing Bioengineering Co., Ltd., Hangzhou, Zhejiang Province, China) at 37°C with 5% CO~2~. Culture medium was changed every 2 days and cells were rinsed with 0.01 M PBS. Cells were subcultured when \> 90% confluence was reached.

Cells cultured with β-asarone and eugenol {#sec2-2}
-----------------------------------------

PC12 cells in the logarithmic growth phase were incubated in 96-well plates; 200 μL of a cell suspension was added into each well at a density of 1 × 10^5^/mL. Cells were subsequently incubated with β-asarone (National Institutes for Food and Drug Control, Beijing; concentration range 1 × 10^-10^ M to 1 × 10^-5^ M in saline), eugenol (National Institutes for Food and Drug Control; concentration range 1 × 10^-10^ M to 1 × 10^-5^ M in saline), a mixture of both, or saline for 24 hours. Then, 0.5 g/mL MTT (Sigma, St. Louis, MO, USA) was added to each well to a final concentration of 10%. After 4 hours of incubation at 37°C, the culture medium was replenished with 150 μL of DMSO (Sigma). Optical density in each group was measured using a microplate reader (Bio-Rad, Hercules, CA, USA). A higher optical density indicated better viability.

Establishing the cell injury model {#sec2-3}
----------------------------------

Aβ42 freeze-dried powder (Anaspec, Fremont, CA, USA) was first dissolved in 1% NH~4~ OH and then added to PBS to a final concentration of 1 × 10^3^ μM, as stock solution. The solution was stored at −20°C before use. In the experiments, Aβ42 stock solution was added to the culture medium to a final concentration of 20 μM (working solution). Cells were firstly incubated at 37°C for at least 24 hours and the culture medium was subsequently changed to another medium containing oligomers of Aβ42 for 24 hours to establish the cell injury model (Togo et al., 2002; Bizzarri et al., 2006).

First, 200 μL of the PC12 cell suspension at a density of 1 × 10^5^/mL was added into each well of a 96-well plate, and cultured with medium containing different concentrations of Aβ42 (0, 10, 20, 30 μM) for 24 hours. Subsequently, MTT (Sigma) was added to each well to a final concentration of 5 mg/mL, and the plate was incubated at 37°C for 4 hours. Then, the medium was replaced with 150 μL of DMSO (Sigma). Cell viability was assessed using the MTT method.

Protective effects of β-asarone and eugenol in the cell injury model {#sec2-4}
--------------------------------------------------------------------

PC12 cells were pre-incubated with β-asarone (1 × 10^-6^ M), eugenol (1 × 10^-7^ M), a mixture of both, and PBS as a negative control in 24-well plates for 24 hours. Then, the culture medium was replaced with medium containing Aβ42 (20 μM), and cells were incubated for 12 hours. After two washes in PBS, cells were incubated with proteinase K working solution (Sigma) at 37°C for 8 minutes. Thereafter, TUNEL staining was carried out to assess the level of cell apoptosis in each group. The pre-incubated groups were then treated with TUNEL reactive solution (Abcam, Cambridge, MA, USA, containing 50 μL of TdT and 450 μL of DAB-stained dUTP), while the model group (PC12 cells pre-incubated with PBS as a negative control in 24-well plates for 24 hours) was treated with TUNEL reactive solution (Abcam; containing 450 μL DAB-stained dUTP) at 25°C for 10 minutes and rinsed three times with PBS. Apoptotic cells in each group were counted six times under a light microscope (Olympus, Tokyo, Japan).

Expression of apoptosis-related factors detected by reverse transcription-PCR {#sec2-5}
-----------------------------------------------------------------------------

The mRNA expression levels of Bax and Bcl-2, which are closely related to cell apoptosis, were measured. Bax mRNA and Bcl-2 mRNA were transcribed in PC12 cells after 0, 1, 3, 6, 12, and 24 hours of incubation with Aβ42 oligomers. β-Asarone (1 × 10^-6^ M), eugenol (1 × 10^-6^ M), a mixture of both, or saline were added after 24 hours of incubation with Aβ42 oligomers, and total RNA was extracted using the TRIzol Plus RNA Purification Kit (Invitrogen Life Technologies, Carlsbad, CA, USA). Forward PCR primers (Bax: 5′-GCG AAT TGG AGA TGA ACT GG-3′, Bcl-2: 5′-CTG GTG GAC AAC ATC GCT CTG-3′, β-actin: 5′-ATG CCA TCC TGC GTC TGG ACC TGG C-3′) and reverse PCR primers (Bax: 5′-GTG AGC GAG GCG GTG AGG AC-3′, Bcl-2: 5′-GGT CTG CTG ACC TCA CTT GTG-3′, β-actin: 5′-AGC ATT TGC GGT GCA CGA TGG AGG G-3′) were used for reverse transcription PCR assays. Thereafter, reverse transcription PCR was performed using an MJ Mini Thermal Cycler (Bio-Rad) and the following program: 95°C for 5 minutes, 25 cycles of 95°C for 30 seconds, 55°C for 30 seconds, 72°C for 1 minute, and an extension at 72°C for 10 minutes. The reverse transcription PCR products were analyzed by 1% agarose gel electrophoresis. β-Actin was used as an internal reference.

Statistical analysis {#sec2-6}
--------------------

Data are presented as the mean ± SD and were analyzed by one-way analysis of variance followed by the least significant difference test. The threshold for significance was *P* \< 0.05, and statistical analysis was performed using SPSS 22.0 software (IBM, Albany, NY, USA).

Results {#sec1-3}
=======

Establishment of the Aβ42-induced cell injury model {#sec2-7}
---------------------------------------------------

After addition of different concentrations of Aβ42 to PC12 cells, the MTT assay was applied to assess the viability of PC12 cells ([**Figure 1**](#F1){ref-type="fig"}). Compared with the control group, significant differences in cell viability were observed in the Aβ 20 μM (*P* = 0.0067) and 30 μM (*P* = 0.0008) groups, while there was no significant difference in viability in the 10 μM Aβ group (*P* = 0.0970).

![Toxic effect of amyloid-beta(Aβ)42 with different concentrations on the viability of PC12 cells as measured by MTT assay.\
Data are presented as the mean ± SD. Results were calculated from six independent experiments. Data were analyzed by one-way analysis of variance combined with the least significant difference test. \*\**P* \< 0.01, *vs*. control group (0).](NRR-10-1292-g001){#F1}

Toxicity of β-asarone and eugenol toward PC12 cells {#sec2-8}
---------------------------------------------------

The viabilities of PC12 cells cultured with β-asarone (1 × 10^-10^ M to 1 × 10^-5^ M) and eugenol (1 × 10^-10^ M to 1 × 10^-5^ M) were similar to those of cells in the control group (*P* \> 0.05), indicating that there were no toxic effects of β-asarone or eugenol at the experimental concentration range ([**Figure 2**](#F2){ref-type="fig"}).

![No toxicity of β-asarone (A) and eugenol (B) toward PC12 cells.\
Data are expressed as the mean ± SD in all cells. Results were calculated from six independent experiments. Data were analyzed by one-way analysis of variance combined with the least significant difference test.](NRR-10-1292-g002){#F2}

Effects of β-asarone and eugenol on PC12 cell apoptosis {#sec2-9}
-------------------------------------------------------

TUNEL staining results showed that, compared with the model group, the rates of apoptosis in PC12 cells incubated with β-asarone, eugenol or a mixture of both were decreased (*P* \< 0.05 or *P* \< 0.01; [**Figure 3**](#F3){ref-type="fig"}).

![Effects of β-asarone and eugenol on PC12 cell apoptosis.\
(A--D) Effect of β-asarone and eugenol on the proportion of TUNEL-positive (apoptosis) PC12 cells. (A) Model group; (B) 1 × 10^-6^ M β-asarone group; (C) 1 × 10^-6^ M eugenol group; (D) 1 × 10^-6^ M β-asarone + 1 × 10^-6^ M eugenol group. Scale bar: 10 μm. (E) Quantification of TUNEL-positive (apoptosis) PC12 cells with each treatment. Data are presented as the mean ± SD. Results were calculated from three independent experiments. Data were analyzed by one-way analysis of variance combined with the least significant difference test. \#*P* \< 0.05, \#\#*P* \< 0.01, *vs*. model group.](NRR-10-1292-g003){#F3}

Expression of apoptosis-related factors in Aβ42-induced PC12 cells {#sec2-10}
------------------------------------------------------------------

The results of reverse transcription PCR showed that, in PC12 cells incubated with Aβ42, Bax mRNA expression increased over time and reached a peak at 24 hours, while Bcl-2 mRNA expression decreased over time and reached the lowest level at 12 and 24 hours ([**Figure 4**](#F4){ref-type="fig"}).

![Levels of mRNAs for Bax and Bcl-2 in PC 12 cells incubated with amyloid-beta(Aβ)42.\
(A) Representative agarose gel electrophoresis bands for reverse transcription PCR products showing the toxicity of Aβ42 toward PC12 cells. (B) Bax mRNA expression in PC 12 cells incubated with Aβ42. (C) Bcl-2 mRNA expression in PC 12 cells incubated with Aβ42. Data are presented as the mean ± SD. Results were calculated from six independent experiments. Data were analyzed by one-way analysis of variance combined with the least significant difference test. \*\**P* \< 0.01, *vs*. control group (0). h: Hour(s).](NRR-10-1292-g004){#F4}

After PC12 cells were pre-co-incubated with β-asarone (1 × 10^-6^ M), eugenol (1 × 10^-6^ M) or a mixture of both, the effects of Aβ42 on the expression levels of apoptosis-related factors, namely Bax and Bcl-2 mRNAs, were all significantly reversed compared with the model group (*P* \< 0.05 or *P* \< 0.01; [**Figure 5**](#F5){ref-type="fig"}).

![The protective effect of β-asarone, eugenol, and a mixture of both on PC12 cell injury models induced by amyloid-beta(Aβ)42.\
(A) Representative agarose gel electrophoresis bands for reverse transcription-PCR products showing the protective effects of β-asarone, eugenol, and a mixture of both on PC12 cells. (B) Protective effect of β-asarone and eugenol in terms of Bax mRNA expression in PC12 cells incubated with Aβ42. (C) Protective effect of β-asarone and eugenol in terms of Bcl-2 mRNA expression in PC12 cells incubated with Aβ42. Data are presented as the mean ± SD. Results were calculated from six independent experiments. Data were analyzed by one-way analysis of variance combined with the least significant difference test. \#*P* \< 0.05, \#\#*P* \< 0.01, *vs*. model group. I: Control group; II: model group; III: 1 × 10^-6^ M β-asarone group; IV: 1 × 10^-6^ M eugenol group; V: 1 × 10^-6^ M β-asarone + 1 × 10^-6^ M eugenol group.](NRR-10-1292-g005){#F5}

Discussion {#sec1-4}
==========

The importance of Aβ42 oligomers in AD {#sec2-11}
--------------------------------------

AD is one of the most common degenerative diseases of the central nervous system, but its specific mechanism of pathogenesis is still unclear. Previous studies have demonstrated that excessive deposition of β-amyloid in brain and excessive phosphorylation of tau are the most important pathogenic mechanisms in AD. The former mechanism, known as the Aβ hypothesis, is widely accepted. Based on this hypothesis, an imbalance between production and clearance of soluble and insoluble Aβ peptide leads to excessive deposition in the hippocampus and cerebral cortex, which are associated with the learning and memory functions of the brain. Excessive deposition usually produces various toxicities toward neurons and finally leads to AD (Lue et al., 1999).

Aβ is derived from the hydrolysis of the amyloid processor protein (APP) by β-secretase and β-secretase enzymes. Two kinds of Aβ, Aβ40 and Aβ42, can form through this pathway (Lu et al., 2013). Aβ42 causes degeneration of synapses and loss of neurons, with toxic effects in the specific brain regions mentioned above (Lu et al., 2013). Several factors are involved in the processing of APP into Aβ, such as caspases and effectors of apoptosis, which are required for apoptosis cascade reactions (Yu et al., 2011; Meesarapee et al., 2014). In addition, processing APP into Aβ is essentially regulated by members of the caspase family. Caspase-3 can cleave APP, influencing the normal metabolism of APP and facilitating the deposition of Aβ (Carvajal et al., 2013; Cetin et al., 2013). Thereafter, caspase-3 receives specific positive feedback from Aβ being stimulated as a result of the toxicity of Aβ. This, in turn, creates a cascade reaction thataccelerates the cleavage of APP and deposition of Aβ, thereby leading to apoptosis of neurons (Niikura et al., 2006; Ghasemi et al., 2014).

An earlier Aβ hypothesis indicated that APP mutations generate Aβ and that increasing levels of Aβ contribute to AD. However, the mechanism underlying the toxicity of Aβ is still unknown (Alvarez-Buylla and Lim, 2004), because there are many forms of Aβ in human brain, including monomers and oligomers, and the deposition of insoluble fibrils has also been shown. Therefore, it is difficult to confirm which factors mediate the pathogenesis of AD (Burdick et al., 1992; Fagan et al., 2006; Wang et al., 2006). Previous studies focused on the toxicities of Aβ contained in senile plaques. However, increasing evidence indicates that Aβ oligomers have a stronger neurotoxicity (Alvarez-Buylla et al., 2000; Kanski et al., 2002; Finder et al., 2010; Nyakas et al., 2011).

Mechanisms underlying the protective effects of β-asarone and eugenol through inhibiting apoptosis-related protein expression {#sec2-12}
-----------------------------------------------------------------------------------------------------------------------------

Preliminary studies in our laboratory have shown that volatile oil extracted from grassleaf sweetflag rhizome can significantly improve learning and memory abilities in AD animal models, which indicates that the volatile oil of grassleaf sweetflag rhizome has an anti-AD and neuron protective effect *in vivo*.

In this study, a PC12 cell injury model was established using Aβ42 to test the protective effects of the main ingredients of grassleaf sweetflag rhizome volatile oil, namely β-asarone and eugenol. Our results showed that β-asarone, eugenol, and mixture of both could prevent the high levels of mRNA expression for the pro-apoptotic protein Bax and the low levels of mRNA expression for the anti-apoptotic protein Bcl-2. The findings in the mixture group were superior to those in either of the single component groups.

Apoptosis-related factors like the pro-apoptotic factors Bax and Bad and the anti-apoptotic factors Bcl-2 and Bcl-XL play important roles in signal transduction during apoptosis (Aimone et al., 2006). Under normal conditions, the Bax/Bcl-2 ratio is a balanced system (Dayer et al., 2005); however, Aβ can facilitate the overexpression of Bax, form a channel in the mitochondrial membrane, and induce cytochrome C transfer into the cytoplasm, which in turn activates the caspase cascade (Matias et al., 2013). That is, apoptosis is induced as a result of disruption of the balance between Bax/Bcl-2. Neuronal apoptosis induced by Aβ primarily operates through the mitochondrial pathway (Zheng et al., 2013; Wang et al., 2014); thus, a certain concentration of Aβ can increase the expression of pro-apoptotic Bax mRNA and decrease the expression of anti-apoptotic Bcl-2 mRNA, consistent with our findings.

Neuroprotective effects of β-asarone, eugenol, and a mixture of both on PC12 cells {#sec2-13}
----------------------------------------------------------------------------------

The PC12 cell line grows fast and stably, is unlikely to automatically transform, and has typical features of neuroendocrine cells (Loeb et al., 1991). Therefore, it is usually used as the ideal cell model for studying the mechanisms underlying neuronal injury and the protective effects of drugs on neurons *in vitro*. In the present study we showed that both β-asarone and eugenol exert protective effects on PC12 cell injury models induced by Aβ42, and that a mixture of both was superior to either single component. This provides evidence that two ingredients of Chinese herbal medicine show efficacy and can potentially be used for the prevention and treatment of AD.
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